基本信息
浏览量:3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Professor Yahya Choonara is internationally recognized as an outstanding global pharmaceutical scientist working at the forefront of producing advanced life-saving 21st century medicines that have an impact on global health in infectious, hereditary and lifestyle diseases. A Pharmacist by profession, he co-founded the University of Witwatersrand’s Wits Advanced Drug Delivery Platform (WADDP) Research Unit, a flagship unit of Wits University and Africa’s largest in its domain. Based in a LMIC he contributed enormously to designing novel targeted drug (and/or bioactive) delivery systems, nanomedicine, functional biomaterials and regenerative medicines. He is a Personal Professor of Pharmaceutical Science in Wits University’s Department of Pharmacy and Pharmacology and is a SA National Research Foundation (NRF) Chair in ‘Pharmaceutical Biomaterials and Polymer-Engineered Drug Delivery Technologies’. As an African academic, he has the largest pharma patent portfolio (47 in total) aimed at providing patient-centric treatments in infectious diseases, oncology, neurotrauma and special needs populations. His inventions include a WaferMat (the world’s fastest dissolving matrix), a VagiTab, Nanomedicine and BioInspired NeuroTherapeutics.
He is an invited/ nominated Fellow of the African Academy of Science (AAS) serving on the Membership Advisory Committee, The World Academy of Science (TWAS), AIM Advisory of the International Pharmaceutical Federation (FIP), Leadership of the American Association of Pharmaceutical Scientists (AAPS) Nanotech Community and the Academy of Science of SA (ASSAf). He features in Stanford University’s Top 2% of (pharma) scientists globally. As a prolific scholar he published >360 research articles in ISI-accredited journals (>9995 citations; H-index=53), 47 book chapters, edited 2 books, made >298 scientific presentations, many as an invited expert e.g. KY’22: US-Africa Frontiers (SEM): ’20 UNECA Nanotech Research and Innovation Forum (Nanomedicine in Infectious Diseases); DNK‘20: Med-Cannabis Seminar (Botanical Therapeutics); JPN‘17: Nobel Laureates Future Leaders STS Forum (Neuro-Implants); IND‘17: BRICS Scientist Conclave (Pseudo-Skin Wound Tech); MUS‘16: Asian Polymer Association (Cancer Targeting); USA ‘10: 37th Controlled Release Society (3D-Bioprinted Scaffolds). He collaborates in >12 countries and reviews for >71 leading journals and funders. He is passionate on developing the next generation of Pharma Scientists and graduated >110 postgraduates and mentored 18 postdocs from 9 countries. He is a Founding Member of the SA Young Academy of Science (SAYAS). The impact of his leadership resulted in many students receiving prestigious awards e.g. Wits Most Prestigious PhD Degree (5 times), Global Young Academy (GYA), M&G Top 200 Young South Africans and the Novartis Next Generation Scientists Program (Basel, AG) (4 times).
He has chaired many national and international scientific committees with >40 invited plenary/keynote addresses. He currently Chair’s the Mobilization Committee of the WHO’s African Pharma Forum (APF)-FIP’s initiative to create the Association of Pharmacy Schools in Africa, seated on the Exco of the SA Association of Pharmacists in Industry (SAAPI) and Pharma Society of SA (APSSA), nominated to the FIP’s Nanjing Statements on Pharmacy and Pharma Sciences Education Policy Committee and contributor to FIP’s Global Academic Leaders Forum. He also serves on many panels/working groups e.g. Pharma-Healthcare for Africa-Asia Partnership (Harvard’s Centre for African Studies), BRICS Business Council Manufacturing Group, SA Department of Science and Innovation (DSI) Nanocode and Nanotechnology for Health, 2010 BIO-Chicago treatise by US Presidents on foreign policy impacting the pharma industry in LMICs. As part of the SA Health Products Regulatory Authority (SAHPRA) Board he provides technical oversight and regulatory strategy and joins global voices advocating to build the pharma industry workforce and research capacity in LMICs for sustainable African Pharma/BioTech sectors. He co-authored two FIP-UNESCO UniTWIN Reports on ‘A Needs-Based Pharma Education in Africa’ and ‘Addressing Equitable, Inclusive and Quality Pharma Education’. He is the first SA Pharmacist to be awarded the DSI (SA) Top IP Creator Award, one of the country’s highest awards for distinguished contributions to innovation and the FIP Distinguished Pharmaceutical Science Award 2022. He also received an AU-TWAS 2015 Award for pharma innovation in Africa, National Science and Technology Foundation 2012 Award for his seminal work in Nanomedicine, SA Medical Research Council (SAMRC) 2019 Award for advancing clinical therapeutics, APSSA Best Publication in Pharmaceutics Award (6 times), Wits Faculty of Health Sciences Research Excellence Award (12 times), Friedel Sellschop Award for decoding pharma formulation optimization and the 2021 VC’s Research Innovation Award, the highest award at Wits for innovation.
研究兴趣
论文共 423 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Expert opinion on drug deliverypp.1-14, (2024)
Drug Delivery and Translational Researchpp.1-27, (2024)
Pharmaceuticsno. 5 (2024): 587
Polymer Bulletinno. 6 (2024): 4819-4849
International Journal of Pharmaceutics (2024): 124182-124182
Biomaterials Advances (2024): 213870-213870
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALSno. 2 (2024): e35376-e35376
AAPS PharmSciTechno. 1 (2024): 1-17
npj Materials Degradationno. 1 (2024): 1-19
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn